GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent


Hitesh

GE HealthCare announced today at the European Congress of Radiology (ECR) in Vienna, Austria that it has completed the registration of Phase I subjects in the initial clinical development program for circumferential magnetic resonance imaging. Manganese-based large-scale, the first contrast agent of its kind (MRI). agency. Typically, MRI agents – […]

OCD-focused platform NOCD raises $35M and more digital health fundings


Hitesh

Digital obsessive-compulsive disorder (OCD) identification and management platform NOCD has closed a $35 million funding round co-led by Cigna Ventures and 7wireVentures. Existing investors F-Prime Capital, Kaiser Permanente Ventures, Health Enterprise Partners and Eight Roads Capital also participated in the round along with new investor Longitude Capital. The Chicago-based company […]

Abbott Receives Approval From Anvisa For Ultreon™, Imaging Technology That Uses Artificial Intelligence For Coronary Arteries


Hitesh

The National Health Surveillance Agency (Anvisa) recently gave its latest optical coherence tomography (OCT) imaging platform with the new UltreonTM Software its seal of approval, according to Abbott. In order to give clinicians an expanded, comprehensive image of coronary blood flow and blockages to support clinical decision-making and provide the […]

Launch of the CE-IVD-Marked HIV-1 Treatment-Resistant Strain Assay by Thermo Fisher Scientific


Hitesh

Thermo Fisher Scientific, a global leader in providing scientific services, today announced the release of its CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a Sanger sequencing-based assay that analyses HIV-positive samples to find genetic variants that may resist conventional antiretroviral therapies. The test’s results can be used to […]